trending Market Intelligence /marketintelligence/en/news-insights/trending/nupGvAKVQubthbsLy8fCgA2 content esgSubNav
In This List

Actinium Pharmaceuticals appoints CEO

Blog

Insight Weekly: Private equity slows; SPAC underwriters retreat; carbon capture boost

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms


Actinium Pharmaceuticals appoints CEO

Actinium Pharmaceuticals Inc. appointed Sandesh Seth as its CEO.

Seth, who is also the company's chairman, will replace Kaushik Dave, who resigned May 12.

Seth is joined by Steve O'Loughlin, who was promoted to the position of principal financial and accounting officer from vice president of corporate finance and development.

Sergio Traversa resigned from the company's board.